Pharmaceuticals, Biotechnology and Life Sciences
The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial discipline.Moody’s affirmed Teva’s…
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…
Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) —…
24 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Update on Cyber Security Incident The Board of DXS International plc (“the…
Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris,…
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food…
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
Seasoned executive brings four decades of finance, capital markets, and life sciences experienceDURHAM, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) —…
RAMAT GAN, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company…
Initial modules submitted to FDA under rolling review; final modules expected in the first half of 2026CANTON, Mass., Dec. 23,…